Immunovia continues with next stage of the Lung Cancer Project together with Global Pharma Partner
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”) today announced that the company’s Lung Cancer collaboration with a global pharmaceutical partner now enters the next stage of the study. The decision to advance was based on the solid progress of the previous study (link to press release ). In this stage of development, Immunovia will receive fresh blood samples from the pharma partner before the end of 2019 to